American Society of Hirudotherapy

Leech Me Alone! Atraumatic Hemarthrosis after Hirudotherapy

Curcio J, Lloyd CM (2020) · Cureus · n=1

RCT evidence detailTrial reference
GRADE Very LowInsufficient evidenceCondition: Knee Osteoarthritis
Sample size of this trial compared with other Knee Osteoarthritis trialsWang H 2018264Lauche R 2025240Lauche R 2014237Farzali S 2025181Cui Y 2024144Andereya S 2008113Andereya S 2008113Sarbaev IS 201996Isik M 201790Curcio J 20201
This trial (highlighted) by sample size alongside other indexed Knee Osteoarthritis trials. Larger trials generally carry more statistical weight.

Study Profile

Design
single case report of atraumatic knee hemarthrosis presenting one week after at-home hirudotherapy for osteoarthritis (OhioHealth Doctors Hospital Emergency Department, Columbus, Ohio, USA)
Sample size (n)
1
Intervention
Description of a 58-year-old male presenting to a US emergency department with knee pain and swelling one week after self-administered leech therapy; knee arthrocentesis demonstrated significant hemarthrosis
Comparator
Not applicable — single-patient safety case report
Primary endpoint
Documentation of intra-articular bleeding as a recognized but under-reported adverse event of hirudotherapy
Primary result
Single case of atraumatic knee hemarthrosis confirmed by arthrocentesis approximately one week after self-administered leech therapy; managed conservatively; authors highlight that intra-articular bleeding is rarely mentioned in published leech-therapy adverse event lists despite cutaneous bleeding, infection, and rash being routinely discussed
Follow-up duration
single ED visit with arthrocentesis-confirmed diagnosis

Key Findings

  • First published case in the US emergency-medicine literature of atraumatic intra-articular hemarthrosis attributable to hirudotherapy
  • Onset approximately one week after leech application — longer than the typical 24-48 hour bleeding window
  • Reinforces that intra-articular bleeding is an under-reported adverse event and is rarely listed in patient-facing counselling materials
  • Strongly supports the ASH not-for-home-use stance — self-administered leech therapy without clinician supervision is hazardous
  • Documents that US emergency physicians encounter this complication and need to be aware of the specific differential diagnosis

Limitations

  • Single case (n=1) - cannot establish incidence rate or risk factors
  • Self-reported leech application protocol details limited
  • No follow-up on subsequent joint function or sequelae reported in abstract
  • Selection bias - case reports tend to over-represent dramatic adverse outcomes
  • Does not generalize to clinically supervised leech therapy with appropriate patient selection

Clinical Implications

Curcio 2020 is the first US emergency-medicine case report of hirudotherapy-induced atraumatic hemarthrosis and provides important safety-surveillance evidence. The case strengthens the ASH editorial position that leech therapy should always be administered under qualified clinician supervision with appropriate patient selection (no coagulopathy, no anticoagulant use, careful site selection). For US emergency clinicians, the report establishes that hemarthrosis can be a delayed (>7 days) complication of self-applied hirudotherapy and should be in the differential for atraumatic joint swelling following CAM bodywork. The trial is cited in the registry as a representative safety counter-signal to the optimistic European OA RCT body.

Related Trials

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.